Longitudinal follow-up of CA125 in peritoneal effluent.
Mesothelial changes occur during peritoneal dialysis. CA125 provides a way to study the mesothelial cells in the in vivo situation. In the present study longitudinal changes of CA125 were analyzed. In addition, the appearance of CA125 in peritoneal effluent and day-to-day variability were studied. CA125 was measured in the effluent of five stable CAPD patients during four hour dwells with 1.36% glucose, with 3.86% glucose and with 7.5% icodextrin. In addition, CA125 was determined on six consecutive days in four hour effluents of three patients and appearance rates (AR) were calculated. Longitudinal follow-up was performed in 31 patients in whom three to seven yearly observations had been made. Linear appearance of CA125 was present in all dwells. No difference was found between the appearance rates of CA125 with 3.86% glucose, compared to either 1.36% glucose or icodextrin. Mean day-to-day coefficient of variation was 6.4% for CA125 AR, but a wide variation existed in stable CA125 values among patients (mean 22.1, range 2 to 48 U/ml). A negative trend with duration of CAPD was present in the longitudinal study. A mean decrease of 2.2% per year could be calculated, but substantial interindividual differences existed. Sudden decreases of CA125 AR were found in five patients. Possible causes were found in all of them and included a severe or recurrent peritonitis, and temporary cessation of peritoneal dialysis. In one patient a sudden decrease preceded the manifestation of peritoneal sclerosis. It can be concluded that CA125 can be used for the in vivo follow-up of the mesothelium in peritoneal dialysis patients. The appearance of CA125 in effluent is linear in time and not influenced by the initial lysis of mesothelial cells. A gradual loss of mesothelial cells is likely to occur, although interindividual variability is substantial. An acceleration of the process may be caused by severe peritonitis and perhaps by temporary cessation of peritoneal dialysis. A sudden decrease in CA125 may be an alarming sign for the development or manifestation of peritoneal sclerosis.
Ho-dac-Pannekeet
M M
MM
Department of Nephrology, Academic Medical Center, Amsterdam, The Netherlands.
Hiralall
J K
JK
Struijk
D G
DG
Krediet
R T
RT
D018394:CA-125 Antigen / Q000378:metabolism*; D015314:Dialysis Solutions / Q000737:chemistry*; D004848:Epithelium / Q000276:immunology / Q000293:injuries / Q000473:pathology; D005355:Fibrosis; D006801:Humans; D008137:Longitudinal Studies; D010530:Peritoneal Dialysis / Q000009:adverse effects; D010537:Peritoneum / Q000276:immunology / Q000293:injuries / Q000473:pathology; D010538:Peritonitis / Q000209:etiology / Q000276:immunology
D018394:CA-125 Antigen; D015314:Dialysis Solutions